Connect your AI

Seaport Therapeutics SPTX Investments

Investments at other companies

Monster BeverageMNST

$770.4M—

CintasCTAS

$407.14M+20.9%

Tenet HealthcareTHC

$3.81B+24.1%

International BancsharesIBOC

$4.98B-1.1%

OGS

ONE GASOGS

$0-100%

Hannon Armstrong Sustainable Infrastructure CapitalHASI

$7.6B+7.7%

Other financials

Income statement

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LongTermInvestments.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Seaport Therapeutics 's investments?: Seaport Therapeutics (SPTX) reported investments of $30.04M in Q1 2026.